Cargando…

Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination

Introduction: Patients (pts) with immune thrombotic thrombocytopenic purpura (iTTP) are at high risk of severe COVID-19, therefore protection from SARS-CoV-2 by vaccination is particularly relevant in this setting, although concerns may exist on possible adverse reactions or disease relapse after va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schieppati, Francesca, Russo, Laura, Marchetti, Marina, Galimberti, Elisa, Palladino, Angela Maria, Gamba, Sara, Verzeroli, Cristina, Tartari, Carmen Julia J, Bolognini, Silvia, Ticozzi, Chiara, Giaccherini, Cinzia, Barcella, Luca, Falanga, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	311.Disorders of Platelet Number or Function: Clinical and Epidemiological
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701612/ http://dx.doi.org/10.1182/blood-2021-153606

Ejemplares similares

Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination
por: Francisco, Michael T., et al.
Publicado: (2021)

Immune Thrombocytopenia Associated with COVID-19 - Case Series
por: Fatkhullin, Ramil, et al.
Publicado: (2020)

Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients
por: Banwait, Ranjit, et al.
Publicado: (2020)

Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Heparin Induced Thrombocytopenia in Patients with COVID-19
por: Warrior, Surbhi, et al.
Publicado: (2020)

Does Thrombocytopenia Truly Correlate with COVID-19 Severity?
por: Hana, Caroline, et al.
Publicado: (2020)

P1696: HEMOSTATIC ACTIVATION MARKERS AND SEROLOGICAL RESPONSE IN SUBJECTS RECEIVING ANTI-COVID-19 VACCINATION
por: Schieppati, F., et al.
Publicado: (2022)

Role of Hemostatic Biomarkers for the Identification of Patients with LONG-COVID19 Syndrome: Results from the 'Accordi' Study
por: Ambaglio, Chiara, et al.
Publicado: (2022)

Inflammatory and Coagulation Biomarkers in Patients with Sars-COV2 Infection Receiving COVID-19 Convalescent Plasma: The Bergamo Registry
por: Marchetti, Marina, et al.
Publicado: (2022)

COVID-19 Vaccination in Adults with Immune Thrombocytopenia (ITP): Data from the Platelet Disorder Support Association (PDSA) Patient Registry
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2021)

Do Splenectomized Immune Thrombocytopenia (ITP) Patients Have Increased Risks for Platelet Decreases Following COVID-19 Vaccination?
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2021)

Spontaneous Heparin-Induced Thrombocytopenia and COVID-19 Infection
por: Amara, Suneetha
Publicado: (2021)

Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

SOCS1 Haploinsufficiency Presenting As Incidental Refractory Thrombocytopenia in a Pediatric Patient with Inflammatory Symptoms and History of Sars Cov-2 Infection
por: Lapinski, Jillian, et al.
Publicado: (2021)

The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia
por: Visser, Chantal, et al.
Publicado: (2021)

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia
por: Lee, Eun-Ju, et al.
Publicado: (2021)

Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab
por: Völker, Linus A., et al.
Publicado: (2020)

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019
Publicado: (2022)

When Third Time's a Charm: Successful Outcome after Third Orthotopic Heart Transplantation
por: Patlolla, Srikant, et al.
Publicado: (2020)

Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura
por: Westwood, John-Paul, et al.
Publicado: (2014)

Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study
por: Huang, Shih-Han Susan, et al.
Publicado: (2021)

The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies
por: Phillips, E. H., et al.
Publicado: (2016)

Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)

P1579: GENOTYPE-PHENOTYPE CORRELATION IN THREE CASES OF PREGNANCY ONSET CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA (CTTP): A SINGLE CENTRE STUDY
por: Schieppati, Francesca, et al.
Publicado: (2023)

Enhanced activity of an ADAMTS‐13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke
por: South, K., et al.
Publicado: (2018)

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients
por: Gomez-Rosas, Patricia, et al.
Publicado: (2023)

IMPACTO DA PANDEMIA DE SARS-COV-2 NA INCIDÊNCIA DE HANSENÍASE NO BRASIL: COMPARAÇÃO COM OS ÚLTIMOS 5 ANOS
por: Pschichholz, Laura
Publicado: (2022)

Facteurs prédictifs d’une poussée de psoriasis après une infection par le SARS-CoV-2 chez l’enfant
por: Mahé, E., et al.
Publicado: (2022)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer
por: Giaccherini, Cinzia, et al.
Publicado: (2022)

P1675: POST-HOSPITAL DISCHARGE EVALUATION OF COVID-19 SURVIVORS WHO SUFFERED ACUTE VENOUS THROMBOEMBOLISM (VTE) DURING HOSPITALIZATION: THE BERGAMO EXPERIENCE
por: Ambaglio, C., et al.
Publicado: (2022)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura()
por: Thomas, Mari R., et al.
Publicado: (2015)

Prasugrel and Acquired Thrombotic Thrombocytopenic Purpura Associated with ADAMTS13 Activity Deficiency
por: Lopez, Yanet Parodis, et al.
Publicado: (2016)

Congenital Thrombotic Thrombocytopenic Purpura With a Novel ADAMTS13 Gene Mutation
por: Rashid, Anila, et al.
Publicado: (2020)

S306: HYPERCOAGULABILITY BIOMARKERS AND THROMBIN GENERATION (TG) PREDICT VENOUS THROMBOEMBOLISM (VTE) IN METASTATIC LUNG CANCER PATIENTS
por: Gomez Rosas, Patricia, et al.
Publicado: (2023)

Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity
por: Tellier, Edwige, et al.
Publicado: (2022)

ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura
por: Manea, Minola, et al.
Publicado: (2006)

Relapsing thrombotic thrombocytopenic purpura with low ADAMTS13 antigen levels: An indication for splenectomy?
por: Lombardi, Anna Maria, et al.
Publicado: (2019)

Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
por: Palandri, Francesca, et al.
Publicado: (2021)

ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
por: Sakai, Kazuya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulvfstlavu55jvnrtmtnqfnhsk